Subject: Imre Asks FDA to Approve Blood Filter for Market
Date: Published: 8/13/85 30 lines
Source:  Wall Street Journal.  Copyright Dow Jones & Co. Inc. 

   Imre Asks FDA to Approve
   Blood Filter for Market

   SEATTLE -- Imre Corp. said it asked the Food and Drug
Administration for permission to market a blood filtration
device for treatment of cancer or immuno-deficiency diseases.
   The device, called Prosorba, is designed to filter a
patient's blood plasma, removing certain harmful molecules
before returning it to the body.  The molecules the filter
removes are thought to block the body's immune system from
fighting disease.
   Frank R. Jones, chairman and chief executive officer of
the biotechnology company, said the device is being tested by
nine institutions on patients suffering from colon and breast
cancers, melanoma, leukemia and Kaposi's sarcoma, a
malignancy linked to acquired immune deficiency syndrome, or
AIDS. 
   Imre said it began clinical tests of the device in 1983,
and expects to publish its results later this year.  The
company hopes to market the device next year.

(This article is made available here by Dow Jones Co. for the 
personal and non-commercial use of callers to this bbs, in the 
hope that it will be of some help to those who are suffering 
from the disease and others who are seeking to help them.)